购物车
0
有库存
HIT220913235
 sdf 文件
结构编辑
类似物检索
HIT220913235
  • HIT ID:HIT220913235
  • Cas No:851606-62-7
  • 常用名:Totrombopag choline
  • IUPAC:(2-hydroxyethyl)trimethylazanium; 5-(3'-{2-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-4-yl]diazen-1-yl}-2'-hydroxy-[1,1'-biphenyl]-3-yl)-1H-1,2,3,4-tetrazol-1-ide
    IUPAC:(2-hydroxyethyl)trimethylazanium; 5-(3'-{2-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-4-yl]diazen-1-yl}-2'-hydroxy-[1,1'-biphenyl]-3-yl)-1H-1,2,3,4-tetrazol-1-ide
  • InChI key:InChIKey=JKVHRBKMPPIUNC-UHFFFAOYSA-N
  • 分子式:C30H35N9O3
  • 分子量:569.67
  • 氢键供体数 (HBD):
  • 氢键受体数 (HBA):
  • LogP:
  • SMILES:C[N+](C)(C)CCO.CC1=NN(C(=O)C1N=Nc1cccc(-c2cccc(c2)-c2nnn[n-]2)c1O)c1ccc(C)c(C)c1
    SMILES:C[N+](C)(C)CCO.CC1=NN(C(=O)C1N=Nc1cccc(-c2cccc(c2)-c2nnn[n-]2)c1O)c1ccc(C)c(C)c1
  • Totrombopag, also known LGD-4665, GSK2285921 and SB559448, is an oral thromobopoietin receptor agonist, is being developed as a new generation small molecule thrombopoietin (TPO) mimetic. It is a highly selective and potent agonist of the TPO receptor and therefore induces differentiation and proliferation of megakaryocytes. The pharmacologic characteristics indicate potential therapeutic use in thrombocytopenic patients with a variety of clinical etiologies.
市场产品/服务共显示1个结果
  • 供应商
    TargetMolSC
    规格
    货期
    8-10周
    纯度
    -
    ¥ 13,900.00
    1

寻找合适的化合物库

您无法确定哪种化合物库最适合您的项目?或者您需要定制解决方案?Anymole随时为您提供帮助。
电话:400820-0310
合作:info@screeningcompound.com
技术支持:tech@screeningcompound.com
客服:service@screeningcompound.com
TargetMol | Target Loading
正在加载 ~